.png){kind=icon}
.png){kind=icon}
Return
Blood-based biomarkers of Alzheimer's disease: potential utility in clinical practice
.png){kind=icon}
OA
AI
Z
N
T
DOI：10.1097/WCO.0000000000001475.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Blood-based biomarkers (BBMs) for Alzheimer's disease are beginning to enter clinical practice. As this integration advances, it is essential to critically examine their strengths, limitations, and readiness for broader clinical application.
Keywords:
Alzheimer's disease
blood-based biomarkers
clinical implementation
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.4
Papers:
2.8K
Citations:
6.5K
Organization
No organization information available
Cited Papers